1,359
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study

ORCID Icon, ORCID Icon, & ORCID Icon
Article: 2153644 | Received 21 Sep 2022, Accepted 25 Nov 2022, Published online: 05 Dec 2022

References

  • Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(Aug 14):4–9.
  • Murray SA, Kendall M, Boyd K, et al. Clinical review Illness trajectories and palliative care. Lancet. 1997 may;24:1007–1011.
  • Decramer M, Janssens W.Chronic obstructive pulmonary disease and comorbidities.Lancet Respir [Internet]. 2021;1(1):73–83.
  • Chronic-obstructive-pulmonary-disease-(COPD) [Internet]. World Health Organization. 2020 Oct 24. [cited 2020 Oct 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
  • Andreassen H, Vestbo J. Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur Respir J. 2003;22(Supplement 46):2s–4s.
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of. COPD GOLD REPORT 2021. 2021.
  • Stevens JP, Dechen T, Schwartzstein RM, et al. Association of dyspnoea, mortality and resource use in hospitalised patients. Eur Respir J. 2021;58(3):online.
  • Brill SE, Wedzicha JA. Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Int J COPD. 2014;9:1241–1252.
  • Aubier M, Murciano D, Milic-Emili J, et al. Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis. 1980;122(5):747–754.
  • Kent BD, Mitchell PD, Mcnicholas WT. Hypoxemia in patients with COPD : cause, effects, and disease progression. Int J COPD. 2011;6:199–208.
  • Chung LP, Winship P, Phung S, et al. Five-year outcome in COPD patients after their first episode of acute exacerbation treated with non-invasive ventilation. Respirology. 2010;15(7):1084–1091.
  • Guideline BTS, Oxygen FOR, Adults IN, et al., BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax an Int J Respir Med. 2017;72(June):1–100.
  • Parshall MB, Schwartzstein RM, Adams L, et al. American Thoracic society documents an official American thoracic society statement : update on the mechanisms, assessment, and management of dyspnea. Amarican J Respir Crit care Med. 2012;185(4):435–452.
  • Mahler DA, Selecky PA, Harrod CG. Management of dyspnea in patients with advanced lung or heart disease. Practical guidance from the American college of chest physicians consensus statement. chest journal, Am Coll chest physicians [Internet]. 2010;120(5):160–166.
  • Cameron L, Pilcher J, Weatherall M, et al. The risk of serious adverse outcomes associated with hypoxaemia and hyperoxaemia in acute exacerbations of COPD. Postgr Med J. 2012;88(september):684–689.
  • Austin MA, Wills KE, Blizzard L, et al. Effect of high flow oxygen on mortality in chronic obstructive randomised controlled trial. BMJ Res. 2010;34(online):1–8.
  • Verberkt CA, Everdingen MHJVDB, Schols JMGA, et al. Respiratory adverse effects of opioids for breathlessness : a systematic review and meta-analysis. (836031012. Eur Respir J. 2017;50(5):1701153.
  • Boon M, Dorp E, Van, Broens S, et al. Combining opioids and benzodiazepines : effects on mortality and severe adverse respiratory events. Ann Palliat Med. 2020;9(2):542–557.
  • Subbe CP, Kruger M, Rutherford P, et al. Validation of a modified early warning score in medical admissions. QJM - Mon J Assoc Physicians. 2001;94(10):521–526.
  • WHO. World medical association declaration of helsinki ethical principles for medical research involving human subjects Clinical Review and Education. 2019;310(30): 2191–2193 .
  • O’Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008;63(SUPPL. 6):vi1–68.
  • Sivapalan P, Lapperre TS, Janner J, et al. Articles Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled. Lancet Respir. 2019;20:6–30176.
  • Walters J, White C, Gibson P, et al. Systematic corticosteoids for acute exacerbations og chronic obstructive pulmonary disease (review). Cochrane Database Syst Rev. 2014;9:391–405.
  • Sivapalan P, Ulrik CS, Lappere TS, et al. Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan. BMC Trails. 2020;1(8): 1–9
  • Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet [Internet]. 2021;391(10131):1693–1705.
  • Echevarria C, Steer J, Wason J, et al. Oxygen therapy and inpatient mortality in COPD exacerbation. Emerg Med J. 2021;38(3):170–177.
  • Ringbaek TJ, Terkelsen J, Lange P. Outcomes of acute exacerbations in COPD in relation to pre-hospital oxygen therapy. European Clinical Respiratory Journal. 2015;1:1–6.
  • Cornet AD, Kooter AJ, Peters MJL, et al. The potential harm of oxygen therapy in medical emergencies. Crit Care. 2013;17(2):313.
  • Plant PK, Owen JL, Elliott MW, et al. One year period prevalence study of respiratory acidosis in acute exacerbations of COPD : implications for the provision of non-invasive ventilation and oxygen administration. Thorax. 2000;55(7):550–554
  • Roberts CM, Stone RA, Buckingham RJ, et al. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax. 2011;66(1):43–48
  • Jayadev A, Stone R, Steiner MC, et al. Time to NIV and mortality in AECOPD hospital admissions : an observational study into real world insights from national COPD audits. BMJ Open Respir Res. 2019;6(1):1–7.
  • Trethewey SP, Edgar RG, Morlet J, et al.Late presentation of acute hypercapnic respiratory failure carries a high mortality risk in COPD patients treated with ward-based NIV.Respir Med [Internet]. 2021;151(January 2019):128–132.
  • Cranston JM, Crockett A, Moss J, et al. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;2008(4).
  • Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. J Am Med Assoc. 2017;317(21):2177–2186.
  • Wijesinghe M, Perrin K, Healy B, et al. Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J. 2009;39(december):1–18.
  • Chen F, Liu L, Wang Y, et al. Delirium prevalence in geriatric emergency department patients: a systematic review and meta-analysis. Am J Emerg Med Internet]. 2022;59:121–128.
  • Grover S, Avasthi A. Clinical practice guidelines for management of delirium in elderly. Indian J Psychiatry. 2018;60(7):S329–40.
  • Ebmeier SJ, Barker M, Bacon M, et al. A two centre observational study of simultaneous pulse oximetry and arterial oxygen saturation recordings in intensive care unit patients. Anaesth Intensive Care. 2018;46(3):297–303.